Huizinga, Robert

Track

Insider profile

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Huizinga, Robert's trades of Kane Biotech Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
161.14
Quantity 39,111
Value CA$1,661,028
Transaction date
Purchase
Price
363.00
Quantity 78,742
Value CA$1,613,663
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-23 2025-01-17
B Purchase
39,111
161.14
CA$1,661,028 		39,111 161.14 CA$1,661,028
2024-09-17 2024-09-13
B Purchase
78,742
363.00
CA$1,613,663 		78,742 363.00 CA$1,613,663